Zofran



Combined with:

Yaz

Indications and Reactions:

Role Indications Reactions
Primary
Nausea 18.1%
Prophylaxis Of Nausea And Vomiting 18.1%
Drug Use For Unknown Indication 17.1%
Product Used For Unknown Indication 11.3%
Vomiting 7.2%
Premedication 4.8%
Chemotherapy 4.1%
Hyperemesis Gravidarum 2.8%
Prophylaxis 2.5%
Breast Cancer 2.4%
Hypertension 1.8%
Depression 1.5%
Pain 1.5%
Drug Exposure During Pregnancy 1.4%
Non-small Cell Lung Cancer 1.4%
Colon Cancer 1.0%
Acute Myeloid Leukaemia 0.9%
Neoplasm Malignant 0.7%
Antiemetic Supportive Care 0.7%
Bronchitis 0.6%
Vomiting 18.5%
Death 15.5%
Drug Ineffective 14.0%
Nausea 7.9%
Drug Exposure During Pregnancy 7.0%
Urticaria 3.4%
Neoplasm Malignant 3.0%
Constipation 2.6%
Rash Papular 2.6%
Weight Decreased 2.6%
Disease Progression 2.5%
Headache 2.5%
Off Label Use 2.5%
Tremor 2.5%
Live Birth 2.3%
Malaise 2.3%
Pharmaceutical Product Complaint 2.3%
Therapeutic Response Unexpected 2.3%
Dizziness 1.9%
Extrapyramidal Disorder 1.9%
Secondary
Product Used For Unknown Indication 28.1%
Nausea 13.3%
Drug Use For Unknown Indication 7.8%
Foetal Exposure During Pregnancy 6.5%
Premedication 6.0%
Breast Cancer 5.9%
Vomiting 5.7%
Prophylaxis 3.7%
Pain 3.3%
Prophylaxis Of Nausea And Vomiting 2.6%
Depression 2.2%
Acute Myeloid Leukaemia 2.1%
Lymphoma 2.0%
Chemotherapy 2.0%
Hypertension 1.8%
Chronic Lymphocytic Leukaemia 1.6%
Constipation 1.6%
Migraine 1.4%
Chronic Obstructive Pulmonary Disease 1.3%
Non-small Cell Lung Cancer 1.3%
Vomiting 19.1%
Nausea 8.2%
Death 6.0%
Premature Baby 6.0%
Shock 6.0%
Weight Decreased 6.0%
Drug Hypersensitivity 5.6%
White Blood Cell Count Decreased 5.6%
Chills 4.5%
Tremor 4.1%
Malaise 3.4%
Respiratory Distress 3.4%
Vertigo 3.4%
Dehydration 3.0%
Pruritus 3.0%
Chest Pain 2.6%
Intra-uterine Death 2.6%
Photosensitivity Reaction 2.6%
Somnolence 2.6%
Drug Ineffective 2.2%
Concomitant
Product Used For Unknown Indication 28.6%
Drug Use For Unknown Indication 17.7%
Nausea 8.9%
Pain 7.3%
Prophylaxis 3.6%
Hypertension 3.2%
Non-small Cell Lung Cancer 3.0%
Breast Cancer 3.0%
Premedication 2.9%
Multiple Myeloma 2.8%
Vomiting 2.7%
Constipation 2.3%
Depression 2.3%
Gastrooesophageal Reflux Disease 2.3%
Anxiety 2.1%
Crohn's Disease 1.8%
Abdominal Pain 1.6%
Insomnia 1.6%
Breast Cancer Metastatic 1.2%
Asthma 1.1%
Vomiting 23.8%
Weight Decreased 8.5%
White Blood Cell Count Decreased 6.0%
Pulmonary Embolism 5.6%
Pyrexia 5.1%
Thrombocytopenia 5.1%
Nausea 5.1%
Death 4.8%
Pneumonia 3.9%
Pain 3.8%
Urinary Tract Infection 3.4%
Suicide Attempt 3.3%
Sepsis 3.0%
Renal Failure 3.0%
Renal Failure Acute 3.0%
Weight Increased 2.8%
Neutropenia 2.6%
Rash 2.5%
Dehydration 2.4%
Diarrhoea 2.3%
Interacting
Lymphoma 26.3%
Smoking Cessation Therapy 10.5%
Cancer Pain 7.9%
Product Used For Unknown Indication 7.9%
Chronic Lymphocytic Leukaemia 5.3%
Epilepsy 5.3%
Acute Lymphocytic Leukaemia 2.6%
Anaemia 2.6%
Anxiety 2.6%
Bacterial Infection 2.6%
Bladder Transitional Cell Carcinoma 2.6%
Chemotherapy 2.6%
Constipation 2.6%
Decreased Appetite 2.6%
Haemoptysis 2.6%
Hypertension 2.6%
Pneumonia 2.6%
Prophylaxis Against Gastrointestinal Ulcer 2.6%
Respiratory Failure 2.6%
Tachycardia 2.6%
Drug Level Decreased 16.7%
Nausea 16.7%
Electrocardiogram Qt Prolonged 8.3%
Hallucination 8.3%
Ileus 8.3%
Nightmare 8.3%
Postoperative Fever 8.3%
Tachycardia 8.3%
Tumour Lysis Syndrome 8.3%
Vision Blurred 8.3%